Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn’s Disease: A Retrospective, Multicentre Study

Background/Objectives: Data on the real-world effectiveness and safety of selective JAK inhibitors (JAKis) in ulcerative colitis (UC) and Crohn’s disease (CD) are limited. Methods: We conducted a multicentre, retrospective study to assess clinical, biochemical, and endoscopic outcomes of selective J...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical medicine 2024-12, Vol.13 (24), p.7804
Hauptverfasser:	Farkas, Bernadett, Bessissow, Talat, Limdi, Jimmy K, Sethi-Arora, Karishma, Kagramanova, Anna, Knyazev, Oleg, Bezzio, Cristina, Armuzzi, Alessandro, Lukas, Milan, Michalopoulos, George, Chaskova, Elena, Savarino, Edoardo Vincenzo, Castiglione, Fabiana, Rispo, Antonio, Schäfer, Eszter, Saibeni, Simone, Filip, Rafal, Attauabi, Mohamed, Fousekis, Fotios S, Bacsur, Péter, Resál, Tamás, Bálint, Anita, Ivány, Emese, Szepes, Zoltán, Bősze, Zsófia, Fábián, Anna, Bor, Renáta, Farkas, Klaudia, Lakatos, Peter L, Molnár, Tamás
Format:	Artikel
Sprache:	eng
Schlagworte:	C-reactive protein Care and treatment Colitis Crohn's disease Disease Diseases Drug therapy Ecuador Endoscopy Ethics Hungary Italy Kinases Medical research Medicine, Experimental Patient outcomes Patients Remission (Medicine) Russia Steroids Tofacitinib Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!